Allergan Rejects $46B Hostile Bid From Valeant, Ackman
Allergan Inc. on Monday rejected an unsolicited takeover offer worth about $46 billion from Valeant Pharmaceuticals Inc. and activist investor Bill Ackman, setting the stage for a high-profile and contentious fight...To view the full article, register now.
Already a subscriber? Click here to view full article